Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

1983studies shown

Showing 1,465-1,476 of 1,983

Other study type icon

RecruitingISRCTN17371456

Protect after depression: a study of a new wellbeing course

This study is recruiting in the United Kingdom. It focuses on depression.

In United Kingdom

DepressionOther

Countries: United Kingdom
Sponsor: University College London (UK)
Condition: Depression

Other study type icon

RecruitingISRCTN21715876

Provision of mental health treatment in general practice settings: outcome and cost effectiveness analysis

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.

In United Kingdom

Schizophrenia, Depression, ...Other

Countries: United Kingdom
Sponsor: NHS R&D Regional Programme Register - Department of Health (UK)
Condition: Schizophrenia, Depression, ...

Other study type icon

RecruitingNCT06898606

Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression

This study is recruiting. It focuses on depression and currently lists participation information in Brazil.

In Foz do Iguaçu

DepressionOtherFrom 25 Years to 65 Years

Countries: Brazil
Sponsor: Federal University of Latin American Integration
Condition: Depression

Drug study icon

RecruitingISRCTN14426797

Psilocybin for depression

This study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.

In United Kingdom

DepressionOther

Countries: United Kingdom
Sponsor: Imperial College London
Condition: Depression

Drug study icon

RecruitingNCT04123314

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In Baltimore

DepressionOtherFrom 18 Years to 85 Years

Countries: United States
Sponsor: Johns Hopkins University
Condition: Depression

Drug study icon

RecruitingNCT06378229

Psilocybin for Hospitalized people with Treatment-resistant Depression

This study is recruiting. It focuses on depression and currently lists participation information in Belgium.

In Ghent

DepressionDrugOver 18 Years

Countries: Belgium
Sponsor: University Hospital, Ghent
Condition: Depression

Drug study icon

RecruitingNCT04754061

PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL)

This study is recruiting. It focuses on depression and currently lists participation information in Canada.

In Ottawa

Depression, AnxietyDrugOver 18 Years

Countries: Canada
Sponsor: Ottawa Hospital Research Institute
Condition: Depression, Anxiety

Drug study icon

RecruitingNCT06731621

Psilocybin for Treatment-Resistant Depression in Autism

This study is recruiting. It focuses on depression and currently lists participation information in Canada.

In Toronto

DepressionOtherFrom 18 Years to 65 Years

Countries: Canada
Sponsor: Centre for Addiction and Mental Health
Condition: Depression

Drug study icon

RecruitingNCT06355414

Psilocybin in Chronic Low Back Pain and Depression

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In Baltimore

DepressionDrugFrom 21 Years to 80 Years

Countries: United States
Sponsor: Johns Hopkins University
Condition: Depression

Drug study icon

RecruitingNCT07183748

Psilocybin Microdosing With Psychotherapy for Treatment-Resistant Depression

This study is recruiting. It focuses on depression and currently lists participation information in Israel.

In Beersheba

DepressionDrugFrom 18 Years to 65 Years

Countries: Israel
Sponsor: Beersheva Mental Health Center
Condition: Depression

Drug study icon

RecruitingNCT06132178

Psilocybin rTMS for Treatment Resistant Depression

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In Austin

DepressionDrugFrom 22 Years to 65 Years

Countries: United States
Sponsor: University of Texas at Austin
Condition: Depression

Drug study icon

RecruitingNCT06455293

Psilocybin Therapy for Depression in Parkinson's Disease

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In San Francisco

DepressionOtherFrom 40 Years to 80 Years

Countries: United States
Sponsor: Joshua Woolley, MD, PhD
Condition: Depression

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.